1-(4-(Trifluoromethyl)phenyl)piperazine

1-(4-(Trifluoromethyl)phenyl)piperazine
Clinical data
Other names	N-(para-[Trifluoromethyl)phenyl]piperazine, 1-(α,α,α-Trifluoro-p-tolyl)piperazine
Pharmacokinetic data
Bioavailability	Unknown
Identifiers
	IUPAC name 1-[4-(Trifluoromethyl)phenyl]piperazine;
CAS Number	30459-17-7 ;
PubChem CID	24887519;
ChemSpider	108602 ;
UNII	VG9TSZ5YPW;
CompTox Dashboard (EPA)	DTXSID80184534 ;
ECHA InfoCard	100.045.631
Chemical and physical data
Formula	C11H13F3N2
Molar mass	230.234 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES FC(F)(F)c1ccc(cc1)N2CCNCC2;
	InChI InChI=1S/C11H13F3N2/c12-11(13,14)9-1-3-10(4-2-9)16-7-5-15-6-8-16/h1-4,15H,5-8H2 ; Key:IBQMAPSJLHRQPE-UHFFFAOYSA-N ;
	(what is this?)

1-[4-(Trifluoromethyl)phenyl]piperazine (pTFMPP) is a serotonergic releasing agent. It is rarely encountered as a designer drug but is much less common than the "normal" isomer meta-TFMPP.^[1]

References

^ "BZP and other piperazines". European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2010.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[1] "BZP and other piperazines". European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2010.

[1]

See also

References